Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Repligen Corp RGEN

Technology Scientific & Technical Instruments
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial... see more

Recent & Breaking News (NDAQ:RGEN)

Repligen to Report Third Quarter 2016 Financial Results

GlobeNewswire October 20, 2016

Repligen Hires Ralf Kuriyel as Senior Vice President of Research & Development

GlobeNewswire October 18, 2016

Repligen Launches Single-Use XCell™ ATF System for Bioprocess Intensification

GlobeNewswire October 5, 2016

Repligen to Present at Baird Global Healthcare Conference 2016

GlobeNewswire September 1, 2016

Repligen Reports Second Quarter 2016 Financial Results

GlobeNewswire August 4, 2016

Repligen to Report Second Quarter 2016 Financial Results

GlobeNewswire July 27, 2016

Repligen to Present at Jefferies 2016 Healthcare Conference

GlobeNewswire June 2, 2016

Repligen to Participate in 13th Annual Craig-Hallum Institutional Investor Conference

GlobeNewswire May 26, 2016

Repligen Announces Pricing of $100 Million of 2.125% Convertible Senior Notes due 2021

GlobeNewswire May 19, 2016

Repligen Announces Proposed Public Offering of $100 Million of Convertible Senior Notes due 2021

GlobeNewswire May 18, 2016

Repligen Reports First Quarter 2016 Financial Results

GlobeNewswire May 5, 2016

Nova LifeStyle has Partnered with Grace Generation Holdings For Digital Marketing

GlobeNewswire May 5, 2016

Repligen to Report First Quarter 2016 Financial Results

GlobeNewswire April 29, 2016

Repligen Acquires Atoll GmbH

GlobeNewswire April 4, 2016

Repligen Forms Scientific Advisory Board

GlobeNewswire March 31, 2016

Repligen Reports Fourth Quarter and Year 2015 Financial Results

GlobeNewswire February 25, 2016

Repligen Announces Extension of Long Term Supply Agreement for Protein A

GlobeNewswire February 24, 2016

Repligen to Report Fourth Quarter and Full Year 2015 Financial Results

Press Releases February 17, 2016

Caladrius Biosciences Licenses Dermatology Cell Technology to AiVita Biomedical

Press Releases February 17, 2016

Enzymotec Ltd. Reports Fourth Quarter and Full Year 2015 Results

Press Releases February 17, 2016